Literature DB >> 12509605

How to interpret radiological progression in randomized clinical trials?

R B M Landewé, M Boers, D M F M van der Heijde.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12509605     DOI： 10.1093/rheumatology/keg062

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Imaging: do erosions heal?

Authors:  D van der Heijde; R Landewé
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up.

Authors:  K Bruynesteyn; R Landewé; Sj van der Linden; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2004-03-22       Impact factor: 19.103

3.  Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Authors:  K Forslind; M Ahlmén; K Eberhardt; I Hafström; B Svensson
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

4.  The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study.

Authors:  Chris D Poole; Pete Conway; Alan Reynolds; Craig J Currie
Journal:  BMC Musculoskelet Disord       Date:  2008-11-04       Impact factor: 2.362
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.